AUPH

MacKay-Dunn R. Hector

Known title: DirectorCIK: 0001838521

MacKay-Dunn R. Hector's purchase track record

MacKay-Dunn R. Hector has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
3/9/2022AUPH$55K+12.4%-41.5%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

AUPH Appears in Report on Activist Investor Activity. Aurinia Pharmaceuticals was mentioned among stocks drawing attention from activist investors, according to recent financial news coverage. No specific activist involvement details or corporate action plans were detailed in the report. The stock is currently trading between its 52-week range extremes, with analysts maintaining price targets notably above current levels.

this person other insiders at AUPH

Transaction History

AUPH▼ Sell$32K
AUPH▼ Sell$54K
AUPH▲ Buy$0
AUPH▲ Buy—
AUPH▲ Buy$55K

We use analytics to understand how market-wall is used. No personal data is sold.